Which hedge funds own OBIO? ORCHESTRA BIOMED HLDGS INC, Q2 2026 13F holders
10 of the hedge funds tracked by WhaleCreep disclosed a position in OBIO (ORCHESTRA BIOMED HLDGS INC) in their Q2 2026 13F filings, worth $73.5m in total. The largest holder by portfolio weight is Propel Bio Management, LLC at 2.0% of its book. 2 managers opened a new position this quarter: Flat Footed LLC, Y-Intercept (Hong Kong) LTD. 11 exited: 683 Capital Management, LLC, Brevan Howard Capital Management LP, Cannon Global Investment Management, LLC.
10tracked managers holding
2opened this quarter
11exited this quarter
Which hedge funds hold OBIO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Propel Bio Management, LLC | Q2 2026 | 2.0% | $3.9m | 896,701 | 0% | held |
| Rtw Investments, LP | Q2 2026 | 0.4% | $41.2m | 9,556,063 | 15% | added |
| Perceptive Advisors LLC | Q2 2026 | 0.3% | $21.7m | 5,037,906 | 0% | held |
| Flat Footed LLC | Q2 2026 | 0.2% | $1.1m | 251,372 | – | new |
| Dafna Capital Management LLC | Q2 2026 | 0.1% | $547.3k | 126,841 | 0% | held |
| Alyeska Investment Group, L.P. | Q2 2026 | 0.0% | $4.3m | 1,000,000 | 0% | held |
| Affinity Asset Advisors, LLC | Q2 2026 | 0.0% | $144.1k | 33,400 | -92% | reduced |
| Y-Intercept (Hong Kong) LTD | Q2 2026 | 0.0% | $187.6k | 43,486 | – | new |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $242.5k | 56,191 | -29% | reduced |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $97.4k | 22,563 | -62% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| 683 Capital Management, LLC | 0.5% | $786.2k |
| Brevan Howard Capital Management LP | 0.0% | $156.3k |
| Cannon Global Investment Management, LLC | 0.5% | $96.1k |
| Catalyst Funds Management Pty LTD | 0.1% | $117.5k |
| Diametric Capital, LP | 0.1% | $80.4k |
| Hudson Bay Capital Management LP | 0.0% | $302.3k |
| Marshall Wace, LLP | 0.0% | $801.1k |
| Millennium Management LLC | 0.0% | $3.0m |
| Prelude Capital Management, LLC | 0.0% | $52.7k |
| Qube Research & Technologies LTD | 0.0% | $463.1k |
| Schonfeld Strategic Advisors LLC | 0.0% | $46.5k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of OBIO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $73.8m |
| Q1 2026 | 21 | $74.2m |
| Q4 2025 | 2 | $1.3m |
| Q3 2025 | 1 | $943.7k |
| Q2 2025 | 1 | $454.0k |
| Q2 2023 | 1 | $88.0k |
Counts every tracked manager that disclosed OBIO in that quarter's filing, including managers that have since stopped filing.